HIF1A and non-small cell lung carcinoma: In AGP-based treatment, down regulation of PI3K/AKT signaling pathway has been observed that accordingly reduce the expression of HIF-1α, a factor for tumor growth in non-small cell lung cancer (NSCLC) by the ubiquitin-dependent degradation (Lin et al., 2011).